Cancer startup Go Therapeutics eyes clinic after $195M Roche deal
October 02, 2018 at 07:00 AM EDT
Cambridge-based immuno-oncology startup Go Therapeutics hopes to send its first drug candidate to the clinic after inking a $195 million deal with drug giant Roche Tuesday.
